Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked)
- People who are having a procedure called PCI (a procedure to open blocked or narrowed heart arteries) where a special balloon coated with medication — called a drug-coated balloon — is planned as part of the treatment
- People having this balloon treatment for various reasons, including stable heart artery disease or more urgent heart conditions such as a heart attack
- People where the balloon treatment is being used on different types of blockages, including new blockages, blockages that have returned inside a previously placed stent, blockages at artery branch points, blockages in small or large arteries, or long-standing complete blockages
- People where the artery was successfully prepared before the balloon was used, meaning the blockage was reduced enough and there were no serious tears in the artery wall (as judged by the treating doctor)
- People for whom complete medical, imaging, and procedure records are available
- People who are able to give their consent to join the study, or whose existing medical data is available for use under local rules for studies that look back at past records
- People who are able to attend planned check-up appointments after the procedure
Who may not be able to join:
- People whose treatment plan does not include a drug-coated balloon — for example, those receiving only a drug-eluting stent (a small mesh tube with medication coating) without the balloon
- People who are in cardiogenic shock (a life-threatening condition where the heart cannot pump enough blood) at the time of the procedure
- People with a non-heart-related illness that means their life expectancy is less than one year
- People who cannot take antiplatelet medications (medicines that help prevent blood clots)
- People with a known severe allergy to the dye used during heart imaging procedures, where pre-treatment to manage the allergy is not possible
- People who are pregnant
- People who would not be able to attend or complete the required follow-up check-ups
- People already taking part in another clinical trial that involves a treatment or intervention that could affect how results are measured
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +905442764616
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Death, target lesion revascularization, target vessel revascularization, myocardial infarction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.